Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.
NCT05106049
·
clinicaltrials.gov ↗
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIAGNOSTIC_TEST:
serum Adiponectin
Sponsor
Assiut University